Aktie A2AGC0 SINCO PHARMACEUTICALS HOLDINGS LIMITED
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Sinco Pharmaceuticals Holdings Limited

Aktien

A2AGC0

KYG8154Y1052

6833

Markt geschlossen - Hong Kong S.E.
Andere Börsenplätze
 10:08:16 02.05.2024 		% 5 Tage % 1. Jan.
0,238 HKD 0,00 % Intraday Chart für Sinco Pharmaceuticals Holdings Limited -2,86 % -0,83 %
26.03. Sinco Pharmaceuticals Holdings Limited berichtet über die Ergebnisse für das am 31. Dezember 2023 endende Geschäftsjahr CI
26.03. Sinco Pharmaceuticals Holdings Limited Rücktritt von Li Kin Wai als Joint Company Secretary und Ernennung von Peng Yunlu zum Executive Director CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Sinco Pharmaceuticals' 2023 Profit Declines on Higher Tax Payments
Sinco Pharmaceuticals Holdings Limited Proposes Final Cash Dividend for the Year Ended 31 December 2023, Payable on 04 June 2024
Sinco Pharmaceuticals Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2023
Sinco Pharmaceuticals Holdings Limited Resignation of Li Kin Wai as Joint Company Secretary and Appointment of Peng Yunlu as Executive Director
Sinco Pharmaceuticals Warns of Lower 2023 Profit
Sinco Pharmaceuticals Holdings Limited Provides Consolidated Earning Guidance for the Year Ended 31 December 2023
Sinco Pharmaceuticals Holdings Limited(SEHK:6833) dropped from S&P Global BMI Index
Sinco Pharmaceuticals Holdings Limited Reports Earnings Results for the Half Year Ended June 30, 2023
Sinco Pharmaceuticals Warns of 68% Drop in H1 Profit
Sinco Pharmaceuticals Holdings Limited Provides Group Earnings Guidance for the Six Months Ended 30 June 2023
Sinco Pharma Taps Moore Advisory Services for Internal Control Review
Sinco Pharmaceuticals Co-CEO Resigns; Shares Slip 3%
Sinco Pharmaceuticals Holdings Limited Announces Final Dividend for the Year Ended 31 December 2022, Payable on June 15, 2023
Sinco Pharmaceuticals Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2022
Sinco Pharmaceuticals Holdings Limited Announces Chief Executive Officer Changes
Sinco Pharmaceuticals Holdings Limited Appoints Lei Shifeng as Executive Director, with Effect from 29 March 2023
Sinco Pharmaceuticals Expects 50% Drop in 2022 Profit; Shares Slip 4%
Sinco Pharmaceuticals Holdings Limited Provides Group Earnings Guidance for the Year Ended 31 December 2022
Sinco Pharmaceuticals Holdings Limited completed the acquisition of Deyang Demei Medical Aesthetic Clinic from Jiang Biao, Jiang Min and Jiang Jun.
Sinco Pharmaceuticals Searching for New Auditor Following EY's Resignation
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A2AGC0 Aktie
  4. Nachrichten Sinco Pharmaceuticals Holdings Limited
  5. Andere Sprachen